SCHEMBL9148372

SCHEMBL9148372

CC1(C)CSc2ccccc2SC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.37
MEN1 O00255 2/20 0.37
GAA P10253 2/20 0.37
KMT2A Q03164 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ACHE P22303 10/20 0.36
ALDH1A1 P00352 3/20 0.34
ALOX12 P18054 2/20 0.34
HPGD P15428 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
CYP1A2 P05177 1/20 0.33
BCHE P06276 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33
MAOA P21397 1/20 0.33
CNR1 P21554 1/20 0.33
PTGS1 P23219 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21662886 0.80 RYR2 (0.37) MAPTMEN1GAAKMT2ANPSR1
SCHEMBL20095222 0.78 ALDH1A1 (0.43) MAPTMEN1GAAKMT2AACHE
SCHEMBL9140221 0.78 MAPT (0.42) MAPTMEN1GAAKMT2ANPSR1
SCHEMBL2632864 0.75 RARA (0.39) NPSR1ALDH1A1ALOX12HPGDLMNA
SCHEMBL8024749 0.71 ALDH1A1 (0.46) MAPTMEN1GAAKMT2ANPSR1
SCHEMBL9531611 0.70 ALDH1A1 (0.33) MAPTACHEALDH1A1ALOX12HPGD
SCHEMBL8013849 0.70 TMEM97 (0.40) MAPTMEN1KMT2AACHEALDH1A1
SCHEMBL19505083 0.69 DAO (0.31)
SCHEMBL29381975 0.69 ALDH1A1 (0.44) MAPTMEN1GAAKMT2ANPSR1
SCHEMBL38579 0.69 ALDH1A1 (0.44) MAPTMEN1GAAKMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0350846-B1 Condensed heterocyclic compounds and their use in therapy HOFFMANN LA ROCHE (CH) 1995-10-11 EP disclosed
US-5420273-A Skin disorders and antitumor agents HOFFMAN-LA ROCHE INC. (US) 1995-05-30 US disclosed
US-5300522-A Treating inflammatory, allergic, rheumatic, immunological disorders HOFFMANN-LA ROCHE INC. (US) 1994-04-05 US disclosed
US-5164387-A Antitumor agents, skin disorders, antiinflammatory agents HOFFMANN-LAROCHE INC. (US) 1992-11-17 US disclosed
US-5037825-A Useful In The Treatment Of Neoplasms, Dermatoses And Aging Of The Skin HOFFMANN-LA ROCHE INC. (US) 1991-08-06 US disclosed
EP-0350846-A2 Condensed heterocyclic compounds and their use in therapy F. HOFFMANN-LA ROCHE AG (CH) 1990-01-17 EP disclosed